O-092 Randomized phase III study of docetaxel (D) versus vinorelbine (V) for elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of a West Japan Thoracic Oncology Group trial (WJTOG9904)

Randomized phase III study of docetaxel (D) versus vinorelbine (V) for elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of a West Japan Thoracic Oncology Group trial (WJTOG9904)

10.1200/jco.2005.23.16_suppl.7009 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7009-7009 ◽

Cited By ~ 4

Author(s):

K. Takeda ◽

S. Kudoh ◽

K. Nakagawa ◽

M. Takada ◽

N. Katakami ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Study ◽

Phase III Study of Docetaxel Compared With Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70415-9 ◽

2007 ◽

Vol 2007 ◽

pp. 198-203

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

The West ◽

Phase Iii Study ◽

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: A phase III study of the Southwest Oncology Group

Lung Cancer ◽

10.1016/0169-5002(94)90869-9 ◽

1994 ◽

Vol 10 (5-6) ◽

pp. 421-422

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Southwest Oncology Group ◽

A Randomized Phase III Study of Single-Agent Amrubicin Vs. Carboplatin/Etoposide in Elderly Patients With Extensive-Disease Small-Cell Lung Cancer

Clinical Lung Cancer ◽

10.1016/j.cllc.2013.11.006 ◽

2014 ◽

Vol 15 (2) ◽

pp. 96-102 ◽

Cited By ~ 15

Author(s):

Ikuo Sekine ◽

Hiroaki Okamoto ◽

Takeshi Horai ◽

Kazuhiko Nakagawa ◽

Hironobu Ohmatsu ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Single Agent ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Extensive Disease ◽

Safety and compliance data of the phase III study of adjuvant chemotherapy for patients (pts) with completely resected, pathological (p-) stage I (T1 > 2 cm) non-small cell lung cancer (NSCLC): A Japan Clinical Oncology Group Trial, JCOG0707.

10.1200/jco.2016.34.15_suppl.8522 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 8522-8522 ◽

Cited By ~ 2

Author(s):

Hideo Kunitoh ◽

Masahiro Tsuboi ◽

Hiroyuki Sakurai ◽

Masashi Wakabayashi ◽

Morihito Okada ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Japan Clinical Oncology Group ◽

Phase Iii Study ◽

Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group

Annals of Oncology ◽

10.1093/annonc/mdm430 ◽

2008 ◽

Vol 19 (1) ◽

pp. 115-122 ◽

Cited By ~ 34

Author(s):

P.A. Kosmidis ◽

H.P. Kalofonos ◽

C. Christodoulou ◽

K. Syrigos ◽

T. Makatsoris ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)

Annals of Oncology ◽

10.1093/annonc/mdq445 ◽

2011 ◽

Vol 22 (4) ◽

pp. 827-834 ◽

Cited By ~ 7

Author(s):

P.A. Kosmidis ◽

G. Fountzilas ◽

A.G. Eleftheraki ◽

H.P. Kalofonos ◽

G. Pentheroudakis ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

9072 POSTER Pemetrexed (Pern) Maintenance Therapy in Elderly Patients (Pts) With Good Performance Status (PS) – Analysis of PARAMOUNT Phase III Study of Pern Versus Placebo in Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC)

European Journal of Cancer ◽

10.1016/s0959-8049(11)72384-x ◽

2011 ◽

Vol 47 ◽

pp. S613 ◽

Cited By ~ 1

Author(s):

C. Gridelli ◽

M. Thomas ◽

K. Prabhash ◽

C. El Kouri ◽

F. Blackhall ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Maintenance Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Randomized phase III study of platinum-doublet chemotherapy followed by gefitinib versus continued platinum-doublet chemotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of West Japan Thoracic Oncology Group trial (WJTOG

10.1200/jco.2008.26.15_suppl.lba8012 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. LBA8012-LBA8012 ◽

Cited By ~ 31

Author(s):

T. Hida ◽

I. Okamoto ◽

T. Kashii ◽

M. Satouchi ◽

Y. Ichinose ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Study ◽

Group Trial ◽

Doublet Chemotherapy ◽

Platinum Doublet

Docetaxel (D) plus gemcitabine (G) compared with G in elderly patients with advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized phase III Hellenic Oncology Research Group trial.

10.1200/jco.2010.28.15_suppl.7605 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7605-7605 ◽

Cited By ~ 5

Author(s):

A. Karampeazis ◽

L. Vamvakas ◽

A. G. Pallis ◽

C. Christophyllakis ◽

N. K. Kentepozidis ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Research Group ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Oncology Research ◽